Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin

International Journal of Dermatology

Volumn 39, Issue 6, 2000, Pages 463-470

  Paasch, Uwe ^a   Haustein, Uwe Frithjof ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLETHRIN; ANTIFUNGAL AGENT; CHLORPHENOTANE; CROTAMITON; IVERMECTIN; LINDANE; PERMETHRIN; PYRETHRIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG COST; DRUG MECHANISM; ELDERLY CARE; ENDEMIC DISEASE; FAMILY; FEMALE; HUMAN; MEDICAL STAFF; NONHUMAN; POPULATION RESEARCH; SARCOPTES SCABIEI; SCABIES; STRUCTURE ANALYSIS; TREATMENT OUTCOME; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALLETHRIN; DISEASE OUTBREAKS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERMANY; HOMES FOR THE AGED; HUMANS; INSECTICIDES; IVERMECTIN; MALE; MIDDLE AGED; NURSING HOMES; PERMETHRIN; PYRETHRINS; SCABIES; SCALP DERMATOSES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033925001     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00990.x     Document Type: Article

References (37)

1. Parish LC, Witkowski JA, Millikan LE. Scabies in the extended care facility. Revisited, lnt J Dermatol 1991; 30: 703-706.
2. Sonnichsen N, Barthelmes H, Barthelmes R. Studies on the increase of scabies. II. Clinical aspects and epidemiology of the current scabies epidemics. Dermatol Monatsschr 1971; 157: 418-431.
3. Orkin M. Resurgence of scabies. JAMA. 1971; 217: 593-597.
4. Kimchi N, Green MS, Stone D. Epidemiologic characteristics of scabies in the Israel Defense Force, lnt J Dermatol 1989; 28: 180-182.
5. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12: 26-33.
6. Parish LC, Millikan LE, Witkowski JA, et al. Scabies in the extended care facility, lnt J Dermatol 1983; 22: 380-382.
7. Elgart MLA. Risk-benefit assessment of agents used in the treatment of scabies. Drug Safety 1996; 14: 386-393.
8. Haustein UF, Hlawa B. Treatment of scabies with permethrin versus lindane and benzyl benzoate. Acta Dermatol Venereol 1989; 69: 348-351.
9. Hernandez-Perez E. Resistance to antiscabietic drugs [letter]. J Am Acad Dermatol 1983; 8: 121-123.
10. Purvis RS, Tyring SK. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream [see comments]. J Am Acad Dermatol 1991; 25: 1015-1016.
11. Karrer S, Szeimies RM, Wlotzke U, et al. Steroid-induced scabies norvegica. Hautarzt 1997; 48: 343-346.
12. Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988; 19: 806-811.
13. Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol 1984; 11: 241-244.
14. Taplin D, Meinking TL. Scabies, lice, and fungal infections. Prim Care 1989; 16: 551-576.
15. Orkin M. Scabies in AIDS. Semin Dermatol 1993; 12: 9-14.
16. Calvo Rodriguez, CE, Menendez Caro JL, Gonzalez Fernandez A, et al. Norwegian scabies in patients with AIDS. Primary prophylaxis in a possible hospital outbreak (letter). Ann Med Intern 1998; 15: 345.
17. Garcia-Pardo G, Simo M, Razquin S, et al. Norwegian scabies and sepsis from Escherichia coli in a HIV infected patient (letter). An Med Intern 1998; 15: 343-344.
18. Dourmishev AL, Serafimova DK, Dourmishev LA, et al. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin. Int J Dermatol 1998; 37: 231-234.
19. Farrell AM, Ross JS, Bunker CB, et al. Crusted scabies with scalp involvement in HIV-1 infection [letter]. Br J Dermatol 1998; 138: 192-193.
20. O'Donnell BF, O'Loughlin S, Powell FC. Management of crusted scabies. Int J Dermatol 1990; 29: 258-266.
21. Taplin D, Rivera A, Walker JG, et al. A comparative trial of three treatment schedules for the eradication of scabies. J Am Acad Dermatol 1983; 9: 550-554.
22. Carslaw JW, Dobson RM, Hood AJ, et al. Mites in the environment of cases of Norwegian scabies. Br J Dermatol 1975; 92: 333-337.
23. Amer M, el Gharib I. Permethrin versus crotamiton and lindane in the treatment of scabies. Int J Dermatol 1992; 31: 357-358.
24. Haustein UF. Pyrethrin and pyrethroid (permethrin) in the treatment of scabies and pediculosis. Hautarzt 1991; 42: 9-15.
25. Taplin D, Meinking TL, Porcelain SL, et al. Permethrin 5% dermal cream: a new treatment for scabies. J Am Acad Dermatol 1986; 15: 995-1001.
26. Taplin D, Meinking TL, Chen JA, et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7: 67-73.
27. Franz TJ, Lehman PA, Franz SF, et al. Comparative percutaneous absorption of lindane and permethrin [see comments]. Arch Dermatol 1996; 132: 901-905.
28. Yonkosky D, Ladia L, Gackenheimer L, et al. Scabies in nursing homes: an eradication program with permethrin 5% cream. J Am Acad Dermatol 1990; 13: 1133-1136.
29. Luffau G, Carrat C, Borgaonkar PW. Biological assay of antihelmintic drugs. Determination of DE 50. Ann Rech Vet 1982; 13: 309-319.
30. Dunne CL, Malone CJ, Whitworth JA. A field study of the effects of ivermectin on ectoparasites of man. Trans R Soc Trop Med Hyg 1991; 85: 550-551.
31. Glaziou P, Cartel JL, Alzieu P, et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993; 44: 331-331.
32. Dourmishev A, Serafimova D, Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 1998; 11: 247-251.
33. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies [letter] [see comments]. Lancet 1997; 349: 1144-1145.
34. Coyne PE, Addiss DG. Deaths associated with ivermectin for scabies [letter; comment]. Lancet 1997; 350: 215-216.
35. Diazgranados JA, Costa JL. Deaths after ivermectin treatment [letter]. Lancet 1997; 349: 1698.
36. Patel A, Hogan P, Walder B. Crusted scabies in two immunocompromised children: successful treatment with oral ivermectin. Australas J Dermatol 1999; 40: 37-40.
37. Tzenow I, Wehmeier M, Melnik B. Oral treatment of scabies with ivermectin. Hautarzt 1997; 48: 2-4.